The FDA’s advisers are expected to vote Thursday on whether the U.S. should be offering just one type of COVID-19 shot for both the primary and booster doses.
The FDA’s advisers are expected to vote Thursday on whether the U.S. should be offering just one type of COVID-19 shot for both the primary and booster doses.
